Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Secures $4M Credit Facility

NEW YORK (GenomeWeb News) - Tm Bioscience said today that it has negotiated a $4 million operating credit facility with Laurus Master Fund.
Tm said it plans to use the funds for general operating purposes while its board of directors completes its previously disclosed review of the company’s strategic alternatives, which include the sale or merger of the company.
As of Sept. 30, Tm had around $4.7 million in cash and cash equivalents.
Net funds available to the company through the credit facility after transaction costs are around $3.85 million.
The facility, which matures on Aug. 31, 2007, is secured by a charge over Tm's assets and carries an interest rate of 7 percent. 
The interest rate will decrease in relation to increases in the company's share price over the term of the facility to a minimum interest rate of 0 percent.
The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.